Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
A single-center random parallel study to compare the efficacy and safety of Mycophenolate
mofetil versus intravenous Cyclophosphamide pulses in the treatment of crescentic IgA
nephropathy